Edward Stadtmauer, MD, chosen as part of Multi-Institutional Myeloma Consortium for Early Phase Myeloma Cancer Trials


April 13, 2010

bizjournals

LOS ANGELES, April 12 /PRNewswire-USNewswire/ -- Aptium Oncology, Inc. today announced the launch of Aptium Oncology Myeloma Consortium (AMyC), a broad-based collaboration that brings together renowned investigators to work with pharmaceutical sponsors to advance clinical and translational research in myeloma and related cancers.

Brian G.M. Durie, M.D., Director, Myeloma Consortium for Aptium Oncology and an internationally recognized expert in multiple myeloma, heads the consortium of investigators and institutions across the United States.  Co-founder of the International Myeloma Foundation (IMF), Dr. Durie is a world-renowned expert in multiple myeloma, as well as highly respected researcher, professor, author and recipient of numerous awards... read more